CHICAGO (GenomeWeb News) — Duke University’s Institute for Genome Sciences and Policy this fall will launch a prospective Phase IIb trial to learn whether a pharmacogenomic-based prognostic model can be used to change the way oncologists treat an early form of non-small cell lung cancer.
 

To read the full story....

Register for Free.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York City medical examiner is overseeing an effort to identify missing persons using DNA, according to the Associated Press.

Nobel laureate Günter Blobel has died at 81, the New York Times reports.

In PNAS this week: mouse model of genetically induced emphysema, gene expression signatures of circulating melanoma cells, and more.

Technology Review reports that 2017 was the year of consumer genetic testing and that it could spur new analysis companies.